WO1994018957A3 - Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung - Google Patents

Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung Download PDF

Info

Publication number
WO1994018957A3
WO1994018957A3 PCT/DE1994/000163 DE9400163W WO9418957A3 WO 1994018957 A3 WO1994018957 A3 WO 1994018957A3 DE 9400163 W DE9400163 W DE 9400163W WO 9418957 A3 WO9418957 A3 WO 9418957A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
active substances
preparing
prepared
substances
Prior art date
Application number
PCT/DE1994/000163
Other languages
English (en)
French (fr)
Other versions
WO1994018957A2 (de
Inventor
Ina Levi
Original Assignee
Ina Levi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4316347A external-priority patent/DE4316347C1/de
Application filed by Ina Levi filed Critical Ina Levi
Priority to AU60374/94A priority Critical patent/AU6037494A/en
Priority to DE4490853T priority patent/DE4490853D2/de
Publication of WO1994018957A2 publication Critical patent/WO1994018957A2/de
Publication of WO1994018957A3 publication Critical patent/WO1994018957A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Verwendung einer Wirksubstanz aus der Gruppe: Tannine, Catechine, Huminstoffe, Huminsäuren, Gallussäure, Gallate, Gerbstoffe, Depside, Gallenextrakte, Ellagsäure, Chikimsäure und Flavonoide sowie Verbindungen, insbesondere Salze, und Derivate und Vorstufen der vorgenannten Substanzen, oder einer Kombination von zwei oder mehreren dieser Wirksubstanzen zur Behandlung von asymptomatischen HIV-Infektionen und/oder anderen retroviral verursachten Erkrankungen und/oder systemischen opportunistischen Infektionen bei Vollbild AIDS und/oder Hepatitis B-Infektionen und/oder Malaria und/oder Krebserkrankungen.
PCT/DE1994/000163 1993-02-26 1994-02-17 Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung WO1994018957A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU60374/94A AU6037494A (en) 1993-02-26 1994-02-17 Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
DE4490853T DE4490853D2 (de) 1993-02-26 1994-02-17 Behandlung von (Retro)viralen Erkrankungen sowie Verfahren zur Herstellung einer pharmazeutischen Zubereitung

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEP4305926.0 1993-02-26
DE4305926 1993-02-26
DEP4316347.5 1993-05-15
DE4316347A DE4316347C1 (de) 1993-02-26 1993-05-15 Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen

Publications (2)

Publication Number Publication Date
WO1994018957A2 WO1994018957A2 (de) 1994-09-01
WO1994018957A3 true WO1994018957A3 (de) 1994-11-10

Family

ID=25923431

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1994/000163 WO1994018957A2 (de) 1993-02-26 1994-02-17 Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung

Country Status (3)

Country Link
AU (1) AU6037494A (de)
DE (1) DE4490853D2 (de)
WO (1) WO1994018957A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7877894A (en) * 1993-09-24 1995-04-10 Maurizio Zanetti Treatment of hiv infection with humic acid
KR100555907B1 (ko) * 2001-04-23 2006-03-03 한국생명공학연구원 엘라그산 유도체를 유효성분으로 함유하는 간염 예방 또는치료용 약학적 조성물
PL2416794T3 (pl) * 2009-04-10 2014-09-30 El Khatib Nadia Kompozycje na bazie roślin do zapobiegania lub leczenia wirusowych chorób przenoszonych przez krew spowodowanych ludzkim wirusem niedoboru odporności (HIV) lub zapalenia wątroby typu C

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2432764A1 (de) * 1974-07-08 1976-01-22 Biofarm Fab Medicament Verfahren und vorrichtung zur gewinnung des peloid-extraktes
DE2846482A1 (de) * 1977-10-25 1979-04-26 Akad Wroclawiu Rolnicza Ein verfahren zur gewinnung eines neoplasmen gegenwirkenden praeparates aus angesaeuertem, alkalischen hydrolysat von torf
WO1990004968A1 (en) * 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition of human retroviruses
EP0374888A2 (de) * 1988-12-20 1990-06-27 Yamanouchi Pharmaceutical Co. Ltd. Sulfatierte Tannine und ihre Salze
WO1992016600A1 (en) * 1991-03-16 1992-10-01 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2432764A1 (de) * 1974-07-08 1976-01-22 Biofarm Fab Medicament Verfahren und vorrichtung zur gewinnung des peloid-extraktes
DE2846482A1 (de) * 1977-10-25 1979-04-26 Akad Wroclawiu Rolnicza Ein verfahren zur gewinnung eines neoplasmen gegenwirkenden praeparates aus angesaeuertem, alkalischen hydrolysat von torf
WO1990004968A1 (en) * 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition of human retroviruses
EP0374888A2 (de) * 1988-12-20 1990-06-27 Yamanouchi Pharmaceutical Co. Ltd. Sulfatierte Tannine und ihre Salze
WO1992016600A1 (en) * 1991-03-16 1992-10-01 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
G.T. TAN ET AL: "Evaluation of natural products as inhibitors of human immunodeficiency virus type-1(HIV-1) reverse transcriptase.", J. NAT. PROD., vol. 54, no. 1, 1991, pages 143 - 154, XP009000240, DOI: doi:10.1021/np50073a012 *
T. MIZUNO ET AL: "Inhibitory effect of tannic acid sulfate and related sulfates on infectivity, cytopathic effect, and giant cell formation of human immunodeficiency virus.", PLANTA MED., vol. 58, no. 6, 1992, pages 535 - 539, XP009104240, DOI: doi:10.1055/s-2006-961544 *

Also Published As

Publication number Publication date
AU6037494A (en) 1994-09-14
WO1994018957A2 (de) 1994-09-01
DE4490853D2 (de) 1996-06-27

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
BR0302672A (pt) Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
IE802676L (en) Sulfonyl ureas.
BR0207294A (pt) Composto, processo para a preparação de um composto ou de um sal farmaceuticamente aceitável ou um éster hidrolisável in vivo dos mesmos, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável ou um éster hidrolisável in vivo dos mesmos, e, método para a produção de um efeito inibitório do ciclo celular (antiproliferação celular) em um animal de sangue quente
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
IE43693L (en) Androstane derivatives
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
NO883074D0 (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
WO1994018957A3 (de) Behandlung von (retro)viralen erkrankungen sowie verfahren zur herstellung einer pharmazeutischen zubereitung
IE45651L (en) Pyrrolobenzoxazaalkane derivatives
IE44339L (en) Piperazine derivatives.
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
BR9915323A (pt) Derivados pirimidina e processos para sua preparação
CA2283739A1 (en) Ascorbic acid as an adjuvant in treatment of malignant tumors by chemotherapy and radiotherapy
EP0173950A3 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
EP0385909A3 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
AR240017A1 (es) Procedimiento de preparacion de una composicion farmaceutica para absorcion percutanea.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REF Corresponds to

Ref document number: 4490853

Country of ref document: DE

Date of ref document: 19960627

WWE Wipo information: entry into national phase

Ref document number: 4490853

Country of ref document: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA